{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:06:40Z","timestamp":1780564000714,"version":"3.54.1"},"reference-count":28,"publisher":"Japanese Society of Veterinary Science","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1292\/jvms.25-0020","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:07:22Z","timestamp":1747174042000},"page":"723-726","source":"Crossref","is-referenced-by-count":1,"title":["Exercise-induced mild rhabdomyolysis associated with oclacitinib in a dog"],"prefix":"10.1292","volume":"87","author":[{"given":"Junya","family":"HIRASHIMA","sequence":"first","affiliation":[{"name":"Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"KOBATAKE","sequence":"additional","affiliation":[{"name":"Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan"},{"name":"Joint Department of Veterinary Medicine, The United Graduate School of Veterinary Science, Gifu University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"NOMURA","sequence":"additional","affiliation":[{"name":"Tanahashi Animal Clinic, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"IWASA","sequence":"additional","affiliation":[{"name":"Hashima Animal Hospital, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"NARITA","sequence":"additional","affiliation":[{"name":"Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadatoshi","family":"MAEDA","sequence":"additional","affiliation":[{"name":"Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan"},{"name":"Joint Department of Veterinary Medicine, The United Graduate School of Veterinary Science, Gifu University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"TAKASHIMA","sequence":"additional","affiliation":[{"name":"Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"NISHII","sequence":"additional","affiliation":[{"name":"Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan"},{"name":"Joint Department of Veterinary Medicine, The United Graduate School of Veterinary Science, Gifu University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anjara P, Jiang M, Mundae M.  2020. Symptomatic elevation creatine kinase following treatment of rheumatoid arthritis with baricitinib. <i>Clin Rheumatol<\/i> 39: 613\u2013614.","DOI":"10.1007\/s10067-019-04833-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Aronson JK, Ferner RE.  2003. Joining the DoTS: new approach to classifying adverse drug reactions. <i>BMJ<\/i> 327: 1222\u20131225.","DOI":"10.1136\/bmj.327.7425.1222"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. B\u00e4cker HC, Richards JT, Kienzle A, Cunningham J, Braun KF.  2023. Exertional rhabdomyolysis in athletes: systematic review and current perspectives. <i>Clin J Sport Med<\/i> 33: 187\u2013194.","DOI":"10.1097\/JSM.0000000000001082"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bouchard J, De La Pena N, Oleksiuk LM.  2019. Levofloxacin-induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review. <i>J Clin Pharm Ther<\/i> 44: 966\u2013969.","DOI":"10.1111\/jcpt.13010"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cervone M, Nectoux A, Pouzot-Nevoret C.  2023. Rhabdomyolysis and myoglobinuria following single induction dose of propofol in a dog. <i>J Vet Emerg Crit Care (San Antonio)<\/i> 33: 118\u2013122.","DOI":"10.1111\/vec.13233"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Coleman JJ, Pontefract SK.  2016. Adverse drug reactions. <i>Clin Med (Lond)<\/i> 16: 481\u2013485.","DOI":"10.7861\/clinmedicine.16-5-481"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cosgrove SB, Wren JA, Cleaver DM, Martin DD, Walsh KF, Harfst JA, Follis SL, King VL, Boucher JF, Stegemann MR.  2013. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. <i>Vet Dermatol<\/i> 24: 479\u2013e114.","DOI":"10.1111\/vde.12047"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cosgrove SB, Cleaver DM, King VL, Gilmer AR, Daniels AE, Wren JA, Stegemann MR.  2015. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. <i>Vet Dermatol<\/i> 26: 171\u2013179, e35.","DOI":"10.1111\/vde.12194"},{"key":"9","unstructured":"9. Graham PA.  2024. Urinalysis. pp. 333\u2013339. In: Ettinger\u2019s Textbook of Veterinary Internal Medicine, 9th ed. (C\u00f4t\u00e9 E, Ettinger SJ, Feldman EC eds.), Elsevier, Amsterdam."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hinchcliff KW, Shaw LC, Vukich NS, Schmidt KE.  1998. Effect of distance traveled and speed of racing on body weight and serum enzyme activity of sled dogs competing in a long-distance race. <i>J Am Vet Med Assoc<\/i> 213: 639\u2013644.","DOI":"10.2460\/javma.1998.213.05.639"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Holahan ML, Littman MP, Hayes CL.  2010. Presumptive hepatotoxicity and rhabdomyolysis secondary to phenazopyridine toxicity in a dog. <i>J Vet Emerg Crit Care (San Antonio)<\/i> 20: 352\u2013358.","DOI":"10.1111\/j.1476-4431.2010.00541.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. John F, Oluronbi R, Pitchumoni CS.  2016. Levofloxacin-induced rhabdomyolysis: a case report. <i>J Med Case Rep<\/i> 10: 235.","DOI":"10.1186\/s13256-016-1004-6"},{"key":"13","unstructured":"13. Mack R.  2024. Creatine kinase. pp. 314\u2013316. In: Ettinger\u2019S Textbook of Veterinary Internal Medicine, 9th ed. (C\u00f4t\u00e9 E, Ettinger SJ, Feldman EC eds.), Elsevier, Amsterdam."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Marsella R, Doerr K, Gonzales A, Rosenkrantz W, Schissler J, White A.  2023. Oclacitinib 10 years later: lessons learned and directions for the future. <i>J Am Vet Med Assoc<\/i> 261 S1: S36\u2013S47.","DOI":"10.2460\/javma.22.12.0570"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Melli G, Chaudhry V, Cornblath DR.  2005. Rhabdomyolysis: an evaluation of 475 hospitalized patients. <i>Medicine (Baltimore)<\/i> 84: 377\u2013385.","DOI":"10.1097\/01.md.0000188565.48918.41"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nash P, Kerschbaumer A, D\u00f6rner T, Dougados M, Fleischmann RM, Geissler K, McInnes I, Pope JE, van der Heijde D, Stoffer-Marx M, Takeuchi T, Trauner M, Winthrop KL, de Wit M, Aletaha D, Baraliakos X, Boehncke WH, Emery P, Isaacs JD, Kremer J, Lee EB, Maksymowych WP, Voshaar M, Tam LS, Tanaka Y, van den Bosch F, Westhovens R, Xavier R, Smolen JS.  2021. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. <i>Ann Rheum Dis<\/i> 80: 71\u201387.","DOI":"10.1136\/annrheumdis-2020-218398"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Papp KA, Krueger JG, Feldman SR, Langley RG, Thaci D, Torii H, Tyring S, Wolk R, Gardner A, Mebus C, Tan H, Luo Y, Gupta P, Mallbris L, Tatulych S.  2016. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study. <i>J Am Acad Dermatol<\/i> 74: 841\u2013850.","DOI":"10.1016\/j.jaad.2016.01.013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Patel R, Sharma JB, Rajput S.  2024. Statins ticagrelor and rhabdomyolysis: a coincidence or a drug interaction? <i>J Lipid Atheroscler<\/i> 13: 61\u201368.","DOI":"10.12997\/jla.2024.13.1.61"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Platt S, Shelton GD.  2013. Exercise intolerance and collapse. pp. 342\u2013367. In: BSAVA Manual of Canine and Feline Neurology, 4th ed. (Platt SR, Olby NJ eds.), New LLL Publisher, Telford.","DOI":"10.22233\/9781910443125.18"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rashid H, Omoloye AK, Abualnaja SY, Oyibo SO, Akintade OO.  2023. A fish farmer\u2019s encounter with leptospirosis: a case report. <i>Cureus<\/i> 15: e48138.","DOI":"10.7759\/cureus.48138"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sandborn WJ, Ghosh S, Panes J, Schreiber S, D\u2019Haens G, Tanida S, Siffledeen J, Enejosa J, Zhou W, Othman AA, Huang B, Higgins PDR.  2020. Efficacy of upadacitinib in a randomized trial of patients with active ulcerative colitis. <i>Gastroenterology<\/i> 158: 2139\u20132149.e14.","DOI":"10.1053\/j.gastro.2020.02.030"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sechi A, Song J, Dell\u2019Antonia M, Heidemeyer K, Piraccini BM, Starace M, Naldi L.  2023. Adverse events in patients treated with Jak-inhibitors for alopecia areata: A systematic review. <i>J Eur Acad Dermatol Venereol<\/i> 37: 1535\u20131546.","DOI":"10.1111\/jdv.19090"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Smith MR, Wurlod VA.  2020. Severe rhabdomyolysis associated with acute amphetamine toxicosis in a dog. <i>Case Rep Vet Med<\/i> 2020: 2816373.","DOI":"10.1155\/2020\/2816373"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Stahl K, Rastelli E, Schoser B.  2020. A systematic review on the definition of rhabdomyolysis. <i>J Neurol<\/i> 267: 877\u2013882.","DOI":"10.1007\/s00415-019-09185-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Taha A, Ahmed S, Ahmed Mbbs R, Mohammed Md A.  2022. Type 2 myocardial infarction related to very low carbohydrate ketogenic diet. <i>J Investig Med High Impact Case Rep<\/i> 10: 23247096221074879.","DOI":"10.1177\/23247096221074879"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Takashima S, Nagamori Y, Ohata K, Oikawa T, Sugaya T, Kobatake Y, Nishii N.  2021. Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs. <i>J Vet Med Sci<\/i> 83: 1465\u20131471.","DOI":"10.1292\/jvms.20-0698"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Valberg SJ.  2018. Muscle conditions affecting sport horses. <i>Vet Clin North Am Equine Pract<\/i> 34: 253\u2013276.","DOI":"10.1016\/j.cveq.2018.04.004"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJA, de Visser M.  2014. Rhabdomyolysis: review of the literature. <i>Neuromuscul Disord<\/i> 24: 651\u2013659.","DOI":"10.1016\/j.nmd.2014.05.005"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/7\/87_25-0020\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T03:34:41Z","timestamp":1751686481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/7\/87_25-0020\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.25-0020","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-0020"}}